<DOC>
	<DOCNO>NCT02148991</DOCNO>
	<brief_summary>Arterial hypertension cause adverse effect entire cardiovascular system , effect centrally diastolic dysfunction structural change leave ventricle , peripherally endothelial dysfunction increase thickness vessel . Co-existing disease , diabetes mellitus , renal dysfunction , sleep apnea , etc . aggravate prognosis patient . In addition rate patient age &gt; 65 year suffer un-diagnosed diagnosed arterial hypertension 78 % woman 64 % male patient . This population consist elderly elderly patient ( 65 80 year respectively ) exhibit comorbidities probably less compliance antihypertensive therapy . Finally , every age disease effect affect quality life patient . The main purpose study investigate efficacy antihypertensive therapy ( irbesartan alone combination amplodipine carvedilol ) cardiovascular system ( diastolic leave ventricular function , function endothelium ( FMD ) thickness common carotid artery ) . The secondary objective study monitor quality life ( Quality Life - QoL ) patient . Additionally investigator seek correlation result co-morbidities , compliance , patient age .</brief_summary>
	<brief_title>Clinical Trial Patients With Hypertension Left Ventricular Dysfunction</brief_title>
	<detailed_description>The scope entire study examine patient follow : : Complete Echocardiographic Study include index leave ventricular mass relative wall thickness ( RWT ) , measurement acquire left parasternal longitudinal axis . Further assessment diastolic function filling pressure leave ventricle use index diastolic function apply patient preserved ejection fraction accord relevant guideline European Society Cardiology . This include tissue velocity mitral annulus ( lateral , septal average ) ratio early diastolic transmitral speed early diastolic mitral annulus velocity . The flow right upper pulmonary vein , record reverse wave . The flow pulmonary vein ( average 3 different measurement ) record additionally . The transmitral A wave duration also measure , Pulsed Doppler sample volume place level mitral annulus ( average 3 different measure ) . The time difference Ar-A ( reverse pulmonary venous - transmitral flow A wave ) calculate . The percentage change E/A ratio Valsalva calculate patient perform substantial Valsalva manoeuvre , absolute decrease E wave least 20 cm / s. Left atrial volume index ( LAVI ) right ventricular systolic pressure ( RVSP ) also estimate . Besides left ventricular diastolic function filling pressure , investigator also estimate diameter ascend aorta aortic arch ( absolute value index body surface area ) . The study endothelial function do method flow-mediated dilatation right brachial artery estimate FMD . Intima-media thickness common carotic artery also perform . Quality life level emotional stress- depression assess use specific questionnaire ( EQ-5D questionnaire , Short Form 36 health survey questionnaire ( SF-36 ) , Beck Depression Inventory ( BDI ) ) . Patient compliance antihypertensive treatment assess follow questionnaire : Brief Medication Questionnaire 1 ( BDQ1 ) , Morisky 8-item Medication Adherence Questionnaire . Additional evaluation assess co-morbidities patient , take detailed medical history initial diagnostic examination ( obstructive sleep apnea , diabetes glycosylated hemoglobin calculation HbA1 , renal impairment calculate creatinine clearance , etc . ) After 'three month ' follow-up investigator evaluate efficacy therapy regulation hypertension patient . Baseline evaluation repeat three month - complete echocardiographic assessment - diastolic leave ventricular dysfunction - patient compliance treatment . Investigators seek correlation co-morbidities patient 's age . - diastolic leave ventricular dysfunction - RWT , - Left ventricular mass index , - LAVI , RVSP , - Ascending Aorta , - Aortic Arch , - FMD , - IMT , - QoL , - emotional stress , - compliance two group , seek correlation co-morbidities patient age .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<mesh_term>Irbesartan</mesh_term>
	<criteria>Age &gt; 18 year Men Women Patients hypertension Patients preserve left ventricular ejection fraction Patients monotherapy irbesartan Patients achieve therapeutic target regulate AP . Patients systolic leave ventricular dysfunction Patients severe mitral aortic valve disease Patients acute coronary acute aortic syndrome Patients febrile infectious disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>